维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

4篇 您的检索式：作者名="Serge Halimi"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Effect of low-dose perindopril/indapamide on albuminuria in diabetes:preterax in albuminuria regression:PREMIER显示文摘	Viberti Serge Halimi	2003	Hypertension2003，41，：	1
	2	End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions显示文摘	Eberhard Ritz Ivan Rychlík Francesco Locatelli Serge Halimi	1999	American Journal of Kidney Diseases1999，，5：	1
	3	Efect of low-dose perindo-pril/indapamide on albuminurla in diabetes:preterax in albuminuria re-gression:PREM IER显示文摘	Carl Erlk Mogensen Viberti Serge Halimi	2003	Hypertension2003，41，：	1
	4	Simple calculator to estimate the medical cost of diabetes in sub-Saharan Africa显示文摘AIM: To design a medical cost calculator and show that diabetes care is beyond reach of the majority particularlypatients with complications.METHODS: Out-of-pocket expenditures of patients for medical treatment of type-2 diabetes were estimated based on price data collected in Benin,Burkina Faso,Guinea and Mali. A detailed protocol for realistic medical care of diabetes and its complications in the African context was defined. Care components were based on existing guidelines,published data and clinical experience. Prices were obtained in public and private health facilities. The cost calculator used Excel. The cost for basic management of uncomplicated diabetes was calculated per person and per year. Incremental costs were also computed per annum for chronic complications and per episode for acute complications. RESULTS: Wide variations of estimated care costs were observed among countries and between the public and private healthcare system. The minimum estimated cost for the treatment of uncomplicated diabetes(in the public sector) would amount to 21%-34% of the country's gross national income per capita,26%-47% in the presence of retinopathy,and above 70% for nephropathy,the most expensive complication. CONCLUSION: The study provided objective evidence for the exorbitant medical cost of diabetes considering that no medical insurance is available in the study countries. Although the calculator only estimates the cost of inaction,it is innovative and of interest for several stakeholders.	Koffi Alouki Hélène Delisle Stéphane Besancon Naby Baldé Assa Sidibé-Traoré Joseph Drabo Francois Djrolo Jean-Claude Mbanya Serge Halimi	2015	World Journal of Diabetes2015，6，16：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费